Back to mobile site

More on CAMP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.1 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/19/26)
- M&A (6/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CAMP4 Therapeutics (NQ:CAMP)
Delayed: 4.25 -0.09 (2.07%)
Prev. Close $4.34  
Open$4.46 
52 Wk High$21.34 
52 Wk Low$12.13 
Day High$4.54 
Day Low$4.21 
P/E 3.20  
EPS$1.33 
Volume101,147 

Friends, Peers and Foes (?): A68, STH XFOR (more...)

Sep 10, 2026 07:33 AM Camp4 Therapeutics gets UK approval for SYNGAP1 drug trial
Sep 10, 2026 07:33 AM CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
Sep 8, 2026 04:05 PM CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
Sep 1, 2026 04:05 PM CAMP4 to Participate in Upcoming Investor Conferences
Aug 26, 2026 04:58 PM Form 4 Camp4 Therapeutics Corp For: Aug 24 Filed by: Schwab Andrew J.
Aug 21, 2026 04:59 PM Form 4 Camp4 Therapeutics Corp For: Aug 19 Filed by: Schwab Andrew J.
Aug 19, 2026 08:46 PM Form 4 Camp4 Therapeutics Corp For: Aug 19 Filed by: Tardiff Daniel
Aug 14, 2026 08:26 AM CAMP4 Therapeutics Corp (CAMP) PT Raised to $15 at Piper Sandler
Aug 14, 2026 05:51 AM Calamp Corp. (CAMP) Misses Q2 EPS by 33c
Aug 13, 2026 04:05 PM CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights  
View All Articles

Entities mentioned with CAMP

View All Entities